Patent · US Active

Sustained release small molecule drug formulation

US10406160B2 · kind B2 · utility

3Cited by

0References

20Claims

0Family size

Assignee

Indivior UK Limited · GB

Inventors

Andrew Luk · Castro Valley, US
Gunjan Junnarkar · Palo Alto, US
Guohua Chen · Sunnyvale, US

Key dates

Filing date	Jul 24, 2018
Grant date	Sep 10, 2019
Priority date	—
Expiry date	Jul 24, 2038

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P25/18
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

An injectable depot formulation includes a biocompatible polymer, an organic solvent combined with the biocompatible polymer to form a viscous gel, and a small molecule drug incorporated in the viscous gel such that the formulation exhibits an in vivo release profile having a Cmax to Cmin ratio of less than 200 and a lag time less than 0.2.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.